IDO1 and melanoma: Specifically, IDO1 inhibition by epacadostat leads to an adverse protection of melanoma cells against IFN-γ-activated T cells, caused by Trp replenishment in the TME that prevents the downregulation of the transcription factor MITF responsible for melanoma cell survival (32).